Journal article
Biosimilars for psoriasis: clinical studies to determine similarity
Abstract
Biosimilars are drugs that are similar, but not identical, to originator biologics. Preclinical analytical studies are required to show similarity on a molecular and structural level, but efficacy and safety studies in humans are essential to determining biosimilarity. In this review, written by members of the International Psoriasis Council, we discuss how biosimilars are evaluated in a clinical setting, with emphasis on extrapolation of …
Authors
Blauvelt A; Puig L; Chimenti S; Vender R; Rajagopalan M; Romiti R; Skov L; Zachariae C; Young H; Prens E
Journal
British Journal of Dermatology, Vol. 177, No. 1, pp. 23–33
Publisher
Oxford University Press (OUP)
Publication Date
7 2017
DOI
10.1111/bjd.15067
ISSN
0007-0963